Failure of current antibiotic first-line regimens and mortality in hospitalized patients with spontaneous bacterial peritonitis

Infection

Volumn 37, Issue 1, 2009, Pages 2-8

  Umgelter, A ^a   Reindl, W ^a   Miedaner, M ^a   Schmid, R M ^a   Huber, W ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CARBAPENEM; CEFOTAXIME; CIPROFLOXACIN; CLAVULANIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ADD ON THERAPY; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL PERITONITIS; BACTERIUM CULTURE; BACTERIUM ISOLATE; BLOOD CULTURE; CLINICAL TRIAL; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; DATA BASE; DISEASE SEVERITY; DRUG TREATMENT FAILURE; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; FEMALE; GERMANY; HOSPITAL INFECTION; HOSPITAL PATIENT; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MICROORGANISM; MORTALITY; MULTIVARIATE ANALYSIS; PATHOGENESIS; PROSPECTIVE STUDY; RISK FACTOR; SEPSIS; SEPTIC SHOCK; TREATMENT RESPONSE; UNIVERSITY HOSPITAL;

AGED; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; DRUG RESISTANCE, BACTERIAL; FEMALE; GERMANY; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; MALE; MIDDLE AGED; PERITONITIS; PROSPECTIVE STUDIES; TREATMENT FAILURE;

EID: 62449259802     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-008-8060-9     Document Type: Article

References (30)

1. Such J, Guarner C, Runyon BA: Pathogenesis and clinical features of spontaneous bacterial peritonitis. In: Ginès P, Arroyo V, Rodés J, Schrier RW (eds) Ascites and renal dysfunction in liver disease. 2nd edition Malden Mass, Blackwell 2005, pp 422-433.
2. G. Garcia-Tsao 2005 Bacterial infections in cirrhosis: treatment and prophylaxis J Hepatol 42 S85 92
3. P. Sort M. Navasa V. Arroyo X. Aldeguer R. Planas L. Ruiz-del-Arbol L. Castells V. Vargas G. Soriano M. Guevara P. Gines J. Rodes 1999 Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis N Engl J Med 341 403 409
4. E. Ricart G. Soriano 2000 Amoxicillin-clavulanic acid versus cefotaxime in the therapy of bacterial infections in cirrhotic patients J Hepatol 32 596 602
5. R. Terg S. Cobas 2000 Oral ciprofloxacin after a short course of intravenous ciprofloxacin in the treatment of spontaneous bacterial peritonitis: results of a multicenter, randomized study J Hepatol 33 564 569
6. J. Felisart A. Rimola V. Arroyo R.M. Perez-Ayuso E. Quintero P. Gines J. Rodes 1985 Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infections Hepatology 5 456 462
7. B.A. Runyon J.G. McHutchison M.R. Antillon E.A. Akriviadis A.A. Montano 1991 Short-course versus long-course antibiotic treatment of spontaneous bacterial peritonitis. A randomized controlled study of 100 patients Gastroenterology 100 1737 1742
8. J. Mercader J. Gomez J. Ruiz M.C. Garre M. Valdes 1989 Use of ceftriaxone in the treatment of bacterial infections in cirrhotic patients Chemotherapy 35 23 26
9. J. Gómez-Jiménez E. Ribera I. Gasser M.A. Artaza O. Del Valle A. Pahissa J.M. Martínez-Vázquez 1993 Randomized trial comparing ceftriaxone with cefonicid for treatment of spontaneous bacterial peritonitis in cirrhotic patients Antimicrob Agents Chemother 37 1587 1592
10. A. Rimola G. García-Tsao 2000 Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club J Hepatol 32 142 153
11. J.D. Grange X. Amiot V. Grange L. Gutmann M. Biour F. Bodin R. Poupon 1990 Amoxicillin-clavulanic acid therapy of spontaneous bacterial peritonitis: a prospective study of twenty-seven cases in cirrhotic patients Hepatology 11 360 364
12. J. Fernandez M. Navasa J. Gomez J. Colmenero J. Vila V. Arroyo J. Rodes 2002 Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis Hepatology 35 140 148
13. N. Singh M.M. Wagener T. Gayowski 2003 Changing epidemiology and predictors of mortality in patients with spontaneous bacterial peritonitis at a liver transplant unit Clin Microbiol Infect 9 531 537
14. B.R.J. Campillo T. Kheo C. Dupeyron 2002 Nosocomial spontaneous bacterial peritonitis and bacteremia in cirrhotic patients: impact of isolate type on prognosis and characteristics of infection Clin Infect Dis 35 1 10
15. Performance Standards for Antimicrobial Susceptibility Testing (2005) Fifteenth International Supplement. Clinical and Laboratory Performance Institute/NCCLS, Wayne.
16. G. Pedersen H.C. Schonheyder F.H. Steffensen H.T. Sorensen 1999 Risk of resistance related to antibiotic use before admission in patients with community-acquired bacteraemia J Antimicrob Chem 43 119 126
17. S.K. Bouchillon B.M. Johnson 2004 Determining incidence of extended spectrum [beta]-lactamase producing Enterobacteriaceae, vancomycin-resistant Enterococcus faecium and methicillin-resistant Staphylococcus aureus in 38 centres from 17 countries: the PEARLS study 2001-2002 Int J Antimicrob Agents 24 119 124
18. M.F.A. Navasa J.M. Llovet G. Clemente V. Vargas A. Rimola F. Marco C. Guarner M. Forne R. Planas R. Banares L. Castells M.T. De Jimenez Anta V. Arroyo J. Rodes 1996 Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis Gastroenterology 111 1011 1017
19. F. Alvarez-Lerma 1996 Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. ICU-Acquired Pneumonia Study Group Intensive Care Med 22 387 394
20. J. Rello M. Gallego D. Mariscal R. Soñora J. Valles 1997 The value of routine microbial investigation in ventilator-associated pneumonia Am J Respir Crit Care Med 156 196 200
21. C.M. Luna P. Vujacich 1997 Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia Chest 111 676 685
22. L. Leibovici I. Shraga M. Drucker H. Konigsberger Z. Samra S.D. Pitlik 1998 The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection J Intern Med 244 379 386
23. G. Behrendt S. Schneider H.R. Brodt G. Just-Nübling P.M. Shah 1999 Influence of antimicrobial treatment on mortality in septicemia J Chemother 11 179 186
24. R.D. MacArthur M. Miller 2004 Adequacy of early empiric antibiotic treatment and survival in severe sepsis: experience from the MONARCS trial Clin Infect Dis 38 284 288
25. J. Garnacho-Montero J.L. Garcia-Garmendia A. Barrero-Almodovar F.J. Jimenez-Jimenez C. Perez-Paredes C. Ortiz-Leyba 2003 Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis Crit Care Med 31 2742 2751
26. K.K. Scarsi J.M. Feinglass M.H. Scheetz M.J. Postelnick M.K. Bolon G.A. Noscin 2006 Impact of inactive empiric antimicrobial therapy on inpatient mortality and length of stay Antimicrob Agents Chemother 50 3355 3360
27. M.H. Kollef G. Sherman S. Ward V.J. Fraser 1999 Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients Chest 115 462 474
28. R.P. Dellinger J.M. Carlet H. Masur H. Gerlach T. Calandra J. Cohen J. Gea-Banacloche D. Keh J.C. Marshall M.M. Parker G. Ramsay J.L. Zimmerman J.L. Vincent M.M. Levy 2004 Surviving Sepsis Campaign Management Guidelines Committee. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock Crit Care Med 23 858 873
29. E. Cholongitas M. Senzolo 2006 Risk factors, sequential organ failure assessment and model for end-stage liver disease scores for predicting short term mortality in cirrhotic patients admitted to intensive care unit Aliment Pharmacol Ther 23 883 893
30. A. Blasco M. Navasa 2005